Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ross Carter

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 20, 2013
Serum amylase on the night of surgery predicts clinically significant pancreatic fistula after pancreaticoduodenectomyLavanniya K Palani Velu, Vishnu V Chandrabalan, Salman Jabbar, et al.
Journal of the National Cancer Institute|August 8, 2015
RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III TrialLavanniya K Palani Velu, Colin W Steele, Euan J Dickson, et al.
Annals of Surgical Oncology|May 5, 2012
The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinomaNigel B Jamieson, Mohamed Mohamed, Karin A Oien, et al.
Plos One|June 30, 2015
SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer PatientsLiane M McGlynn, Simon McCluney, Nigel B Jamieson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2011
MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinomaNigel B Jamieson, Douglas C Morran, Jennifer P Morton, et al.
BMC Clinical Pathology|July 30, 2014
Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panelAsif Ali, Victoria Brown, Simon Denley, et al.
The Journal of Pathology|May 8, 2015
CXCR2 inhibition suppresses acute and chronic pancreatic inflammationColin W Steele, Saadia A Karim, Mona Foth, et al.
Chinese Clinical Oncology|May 10, 2019
Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profilingStephan B Dreyer, Nigel B Jamieson, Lisa Evers, et al.
Gastroenterology|January 28, 2014
Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomesAng Li, Jennifer P Morton, YaFeng Ma, et al.
Gut|April 11, 2014
Targeting mTOR dependency in pancreatic cancerDouglas C Morran, Jianmin Wu, Nigel B Jamieson, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 20, 2013
Serum amylase on the night of surgery predicts clinically significant pancreatic fistula after pancreaticoduodenectomyLavanniya K Palani Velu, Vishnu V Chandrabalan, Salman Jabbar, et al.
Journal of the National Cancer Institute|August 8, 2015
RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III TrialLavanniya K Palani Velu, Colin W Steele, Euan J Dickson, et al.
Annals of Surgical Oncology|May 5, 2012
The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinomaNigel B Jamieson, Mohamed Mohamed, Karin A Oien, et al.
Plos One|June 30, 2015
SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer PatientsLiane M McGlynn, Simon McCluney, Nigel B Jamieson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2011
MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinomaNigel B Jamieson, Douglas C Morran, Jennifer P Morton, et al.
BMC Clinical Pathology|July 30, 2014
Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panelAsif Ali, Victoria Brown, Simon Denley, et al.
The Journal of Pathology|May 8, 2015
CXCR2 inhibition suppresses acute and chronic pancreatic inflammationColin W Steele, Saadia A Karim, Mona Foth, et al.
Chinese Clinical Oncology|May 10, 2019
Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profilingStephan B Dreyer, Nigel B Jamieson, Lisa Evers, et al.
Gastroenterology|January 28, 2014
Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomesAng Li, Jennifer P Morton, YaFeng Ma, et al.
Gut|April 11, 2014
Targeting mTOR dependency in pancreatic cancerDouglas C Morran, Jianmin Wu, Nigel B Jamieson, et al.
Pageof 3